$2500 | Single User
$5000 | Site License
$7500 | Global License

Choroidal Neovascularization Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

Published by Global Data: 31 Dec 2018 | 230700 | In Stock

Introduction

Choroidal Neovascularization Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, “Choroidal Neovascularization Global Clinical Trials Review, H2, 2018" provides an overview of Choroidal Neovascularization clinical trials scenario. This report provides top line data relating to the clinical trials on Choroidal Neovascularization. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Choroidal Neovascularization Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    GlobalData Clinical Trials Report Coverage 6

    Clinical Trials by Region 7

    Clinical Trials and Average Enrollment by Country 8

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

    Top Five Countries Contributing to Clinical Trials in Europe 12

    Top Countries Contributing to Clinical Trials in North America 13

    Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14

    Top Five Countries Contributing to Clinical Trials in Central and South America 15

    Clinical Trials by G7 Countries: Proportion of Choroidal Neovascularization to Ophthalmology Clinical Trials 16

    Clinical Trials by Phase in G7 Countries 17

    Clinical Trials in G7 Countries by Trial Status 18

    Clinical Trials by E7 Countries: Proportion of Choroidal Neovascularization to Ophthalmology Clinical Trials 19

    Clinical Trials by Phase in E7 Countries 20

    Clinical Trials in E7 Countries by Trial Status 21

    Clinical Trials by Phase 22

    In Progress Trials by Phase 23

    Clinical Trials by Trial Status 24

    Clinical Trials by End Point Status 25

    Subjects Recruited Over a Period of Time 26

    Clinical Trials by Sponsor Type 27

    Prominent Sponsors 28

    Top Companies Participating in Choroidal Neovascularization Therapeutics Clinical Trials 30

    Prominent Drugs 32

    Clinical Trial Profile Snapshots 33

    Appendix 248

    Abbreviations 248

    Definitions 248

    Research Methodology 249

    Secondary Research 249

    About GlobalData 250

    Contact Us 250

    Source 250

List Of Tables
in Choroidal Neovascularization Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

List of Tables

Choroidal Neovascularization Therapeutics, Global, Clinical Trials by Region, 2018* 7

Choroidal Neovascularization Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

Choroidal Neovascularization Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Choroidal Neovascularization Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11

Choroidal Neovascularization Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12

Choroidal Neovascularization Therapeutics Clinical Trials, North America, Top Countries, 2018* 13

Choroidal Neovascularization Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14

Choroidal Neovascularization Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15

Proportion of Choroidal Neovascularization to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 16

Choroidal Neovascularization Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Choroidal Neovascularization Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18

Proportion of Choroidal Neovascularization to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 19

Choroidal Neovascularization Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20

Choroidal Neovascularization Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21

Choroidal Neovascularization Therapeutics, Global, Clinical Trials by Phase, 2018* 22

Choroidal Neovascularization Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 23

Choroidal Neovascularization Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24

Choroidal Neovascularization Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25

Choroidal Neovascularization Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26

Choroidal Neovascularization Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 27

Choroidal Neovascularization Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 29

Choroidal Neovascularization Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 31

Choroidal Neovascularization Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 32

List Of Figures, Charts and Diagrams
in Choroidal Neovascularization Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

List of Figures

Choroidal Neovascularization Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Choroidal Neovascularization Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Choroidal Neovascularization Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Choroidal Neovascularization Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11

Choroidal Neovascularization Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12

Choroidal Neovascularization Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13

Choroidal Neovascularization Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14

Choroidal Neovascularization Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15

Proportion of Choroidal Neovascularization to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 16

Choroidal Neovascularization Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Choroidal Neovascularization Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18

Proportion of Choroidal Neovascularization to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 19

Choroidal Neovascularization Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20

Choroidal Neovascularization Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21

Choroidal Neovascularization Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22

Choroidal Neovascularization Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 23

Choroidal Neovascularization Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24

Choroidal Neovascularization Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25

Choroidal Neovascularization Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26

Choroidal Neovascularization Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 27

Choroidal Neovascularization Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28

Choroidal Neovascularization Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30

Choroidal Neovascularization Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 32

GlobalData Methodology 249

Additional Details

Publisher

Global Data

Publisher Information

Reference

230700 | GDHC5564CTIDB

Number of Pages

250

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Choroidal Neovascularization - Pipeline Review, H2 2017
Choroidal Neovascularization - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmac...
30 Sep 2017 by Global Markets Direct USD $2,000 More Info
Choroidal Neovascularization - Pipeline Insight, 2017
DelveInsight’s, “ Choroidal Neovascularization -Pipeline Insights, 2017”, report provides comprehens...
10 Jul 2017 by Delve Insight USD $1,250 More Info
Choroidal Neovascularization - Market Insights, Epidemiology and Market Forecast – 2025
DelveInsight’s “Choroidal Neovascularization - Market Insights, Epidemiology and Market Forecast – 2...
10 Jul 2017 by Delve Insight USD $5,750 More Info
Choroidal Neovascularization - Epidemiology Insights to 2025
DelveInsight “ Choroidal Neovascularization - Epidemiology Forecast To 2025” provides an overview of...
10 Jul 2017 by Delve Insight USD $2,950 More Info
Choroidal Neovascularization Global Clinical Trials Review, H1, 2017
Choroidal Neovascularization Global Clinical Trials Review, H1, 2017SummaryGlobalData's clinical tri...
30 Jun 2017 by Global Data USD $2,500 More Info
Choroidal Neovascularization-Pipeline Insights, 2017
DelveInsight’s, “ Choroidal Neovascularization-Pipeline Insights, 2017”, report provides in depth in...
30 May 2017 by Delve Insight USD $1,250 More Info
Choroidal Neovascularization - Pipeline Review, H1 2017
Choroidal Neovascularization - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmac...
28 Apr 2017 by Global Markets Direct USD $2,000 More Info
Choroidal Neovascularization Global Clinical Trials Review, H1, 2016
Choroidal Neovascularization Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical tri...
30 Apr 2016 by Global Data USD $2,500 More Info
Choroidal Neovascularization Global Clinical Trials Review, H1, 2016
Choroidal Neovascularization Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical tri...
30 Apr 2016 by Global Data USD $2,500 More Info
Choroidal Neovascularization (CNV) Market: By Treatment Type (Angiogenesis Inhibitors Injection, Photodynamic Therapy, Laser photocoagulation, Low-dose, Radiation Therapy, Surgery), By Diagnosis Types & By Geography- Forecast (2016- 2021)
Choroidal Neovascularization (CNV) is rapidly occurring in the population with defects in the innerm...
05 Feb 2016 by Industry ARC USD $5,250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Choroidal Neovascularization Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data